Article | May 24, 2021

Five Clinical Trial Diversity Action Steps You Can Take Today

Source: Greenphire

By Amy Sitnick

Diversity.jpg

Diversity has certainly taken center stage in the clinical trial industry, with the FDA issuing guidance on the matter in November 2020: Enhancing the Diversity of Clinical Trial Populations – Eligibility Criteria, Enrollment Practices and Trial Designs Guidance for Industry. Here at Greenphire, we’ve observed many organizations looking to make a difference in this arena, both before and increasingly after the FDA guidance.

To help guide organizations move beyond the problems that exist and discuss approaches and solutions, the DIA hosted their first ever meeting dedicated exclusively to Diversity, Equity and Inclusion in the Drug Development Lifecycle.

In this article, I’d like to share some of the key learnings from the event, so that you may brainstorm with your colleagues and connections, building further connection and action plans.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: